THE Pan American Health Organization (PAHO) has issued an epidemiological alert regarding possible cases of expectant mother-to-child transmission of the Oropouche virus (OROV) that was first detected in Trinidad and Tobago in 1955.

In a statement, PAHO said that it was informing its member states about the identification of possible cases of OROV in Brazil and is calling for strengthened surveillance to monitor the potential occurrence of similar events in other countries with circulation of OROV and other arboviruses.

OROV is transmitted by bites of an insect commonly known as a midge, as well as by the Culex mosquito.

It was first detected in Trinidad and Tobago in 1955 and, since then, sporadic outbreaks have been documented in several countries in the Americas.

PAHO said recently, an increase in cases has been observed in the region. It said between January and mid-July 2024, nearly 7,700 confirmed cases of Oropouche have been reported in five countries in the Americas, with Brazil having the highest number (6,976).

The identification of suspected mother-to-child transmission of the virus occurs against the backdrop of this increase in reported cases, it said, adding that in a recent case, a pregnant woman presented symptoms of Oropouche during the 30th week of gestation.

“Following laboratory confirmation of OROV infection, foetal death was subsequently reported. The possible vertical transmission and consequences in the foetus are still under investigation,” PAHO states in the epidemiological alert.

“However, this information is shared with member states to make them aware of the situation and at the same time request that they be alert to the occurrence of similar events in their territories,” it adds, with the aim of increasing understanding about this possible route of transmission and its implications.

Since the increase in the number of cases in the region, PAHO said it has organised various activities, such as an international workshop on the molecular surveillance for emerging and re-emerging arboviruses, which brought together health experts and researchers from Bolivia, Ecuador, Guyana, Paraguay, Peru, Suriname, Venezuela, and Brazil.

On Wednesday, PAHO issued guidelines to assist countries in the detection and surveillance of Oropouche and possible cases of mother-to-child infection, congenital malformation, or foetal death.

PAHO said it is working closely with countries where cases have been confirmed to share knowledge and experience.

Symptoms of the disease include the sudden onset of fever, headache, joint stiffness, aches and pains and, in some cases, photophobia, nausea and persistent vomiting that can last five to seven days. Although severe clinical presentation is rare, it may evolve to aseptic meningitis. Full recovery can take several weeks.

To control Oropouche, PAHO calls on countries to implement vector prevention and control actions, including strengthening entomological surveillance, reducing populations of mosquito and other transmitting insects, and educating the population, especially pregnant women, about personal protective actions to prevent bites.

Recommended measures include protecting homes with fine-mesh mosquito nets on doors and windows; wearing clothing that covers arms and legs, especially in homes where there are sick people; and applying repellent.